RETATRUTIDE
RETATRUTIDE
Couldn't load pickup availability
Retatrutide
Triple Agonist | GIP • GLP-1 • Glucagon
Retatrutide is a next-generation peptide designed to target GIP, GLP-1, and glucagon receptors, enabling simultaneous multi-pathway metabolic signaling. Engineered for advanced research applications, it provides a broader and more integrated signaling profile than traditional single- or dual-agonist compounds—supporting investigation into energy balance, glucose regulation, and weight-related mechanisms.
________________________________________
Specifications
• Form: Lyophilized powder Freeze-dried powder form for stable storage and easy reconstitution.
• Quantity: 20 mg per vial
• 99% Purity – HPLC Tested
________________________________________
Handling & Storage
Store in a cool, dry place away from light. Refrigeration required after reconstitution store between 5-8 degrees
________________________________________
Quality Standard
Lab Tested and Manufactured under controlled conditions and supplied as research-grade material.
________________________________________
Shipping
Express shipping available within Australia.
________________________________________
Regulatory Notice: For research use ONLY. Not for human consumption.
Share
